Skip to main content

Table 1 The status of RR-TB detection, FQs resistance testing and PMDT coverage in China, 2015–2019

From: Characteristics of rifampicin-resistant tuberculosis detection in China, 2015–2019

Year

RR-TB cases detected

RR screening rate (%)

Proportion of FQs screening in RR-TB cases (%)

Prefecture-level coverage rate for PMDT (%)

All

New cases

n (%)

High-risk groups

n (%)

All

New cases

High-risk groups

All

New cases

High-risk groups

2015

10 019

3971 (39.6)

6048 (60.4)

29.5

23.1

57.3

57.8

58.6

57.2

70.0

2016

11 423

4564 (40.0)

6859 (60.0)

28.6

22.8

54.8

59.6

60.3

59.0

70.0

2017

13 069

6227 (47.6)

6842 (52.4)

37.8

33.1

57.2

51.9

52.7

51.1

78.0

2018

15 066

7807 (51.8)

7259 (48.2)

62.8

60.2

72.6

48.2

51.3

45.0

90.0

2019

18 623

10 204 (54.8)

8419 (45.2)

81.9

80.4

88.4

41.0

42.7

39.0

95.0

Total

68 200

32 773 (48.1)

35 427 (51.9)

49.4

45.3

67.2

50.3

51.0

49.6

  1. RR-TB Rifampicin-resistant tuberculosis, FQs Fluoroquinolones, PMDT Programmatic Management of Drug-resistant Tuberculosis